Iron and senile plaques deposition in transgenic mouse model of Alzheimer' s disease and influence on MR T 2 relaxation times

Chinese Journal of Neurology

Volumn 43, Issue 9, 2010, Pages 626-631

  Wang, Dong ^a   Zhang, Lin Hong ^b   Xu, Wei ^b   Du, Xiao Xia ^b   Zhan, Yan Qiang ^a   Zhang, Su Ming ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b NONE

Author keywords

Alzheimer disease; Iron; Magnetic resonance imaging; Mice, transgenic; Senile plaques; Time

Indexed keywords

IRON;

AGED; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CORTEX; COMPUTER PROGRAM; CONTROLLED STUDY; CORPUS STRIATUM; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; EXPERIMENTAL MODEL; GROUPS BY AGE; HIPPOCAMPUS; IMAGING SYSTEM; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; SENILE PLAQUE; SENSITIVITY AND SPECIFICITY; THALAMUS; TRANSGENIC MOUSE; WILD TYPE;

EID: 84860601158     PISSN: 10067876     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.1006-7876.2010.09.008     Document Type: Article

References (14)

1. Garcia-Alloza M, Robbins E M, Zhang-Nunes S X, et al. Characterization of amyloid deposition in the APPswe/PSldE9 mouse model of Alzheimer disease. Neurobiol Dis, 2006, 24: 516-524.
2. Smith M A, Harris P L, Sayre L M, et al. Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. Proc Natl Acad Sci USA, 1997, 94: 9866-9868.
3. Smith M A. Oxidative stress and iron imbalance in Alzheimer disease: how rust became the fuss! J Alzheimers Dis, 2006, 9(3 Suppl): 305-308.
4. Nunomura A, Perry G, Aliev G, et al. Oxidative damage is the earliest event in Alzheimer disease. J Neuropathol Exp Neurol, 2001, 60: 759-767.
5. El Tannir El Tayara N, Delatour B, Le Cudennec C, et al. Age-related evolution of amyloid burden, iron load, and MR relaxation times in a transgenic mouse model of Alzheimer's disease. Neurobiol Dis, 2006, 22: 199-208.
6. El Tayara Nel T, Volk A, Dhenain M, et al. Transverse relaxation time reflects brain amyloidosis in young APP/PS1 transgenic mice. Magn Reson Med, 2007, 58: 179-184.
7. Faber C, Zahneisen B, Tippmann F, et al. Gradient-echo and CRAZED imaging for minute detection of Alzheimer plaques in an APPV717I x ADAMlO-dn mouse model. Magn Reson Med, 2007, 57: 696-703.
8. Zhu W Z, Zhong W D, Wang W, et al. Quantitative MR phase-corrected imaging to investigate increased brain iron deposition of patients with Alzheimer disease. Radiology, 2009, 253: 497-504.
9. Nakada T, Matsuzawa H, Igarashi H, et al. In vivo visualization of senile-plaque-like pathology in Alzheimer's disease patients by MR microscopy on a 7T system. J Neuroimaging, 2008, 18: 125-129.
10. Wadghiri Y Z, Sigurdsson E M, Sadowski M, et al. Detection of Alzheimer's amyloid in transgenic mice using magnetic resonance microimaging. Magn Reson Med, 2003, 50: 293-302.
11. Mueggler T, Meyer-Luehmann M, Rausch M, et al. Restricted diffusion in the brain of transgenic mice with cerebral amyloidosis. Eur J Neurosci, 2004, 20: 811-817.
12. Marjanska M, Curran G L, Wengenack T M, et al. Monitoring disease progression in transgenic mouse models of Alzheimer s disease with proton magnetic resonance spectroscopy. Proc Natl Acad Sci USA, 2005, 102: 11906-11910.
13. 2007, 40: 23-26.
14. Crapper McLachlan D R, Dalton A J, Kruck T P, et al. Intramuscular desferrioxamine in patients with Alzheimer's disease. Lancet, 1991, 337: 1304-1308.